InsidersTradesSigma
Track the NeuroSense Therapeutics Ltd. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). The latest transaction was disclosed on 17 June 2026 (Acquisition). Among the most active insiders: Ben-Noon Alon. Every trade is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
NeuroSense Therapeutics Ltd. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades neurodegenerativas. Cotiza en el NASDAQ.